Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes

Nature Immunology volume 10, pages 1026–1033 (2009)Cite this article

Abstract

Type 1 diabetes may result from a breakdown in peripheral tolerance that is partially controlled by the expression of peripheral tissue antigens (PTAs) in lymph nodes. Here we show that the transcriptional regulator Deaf1 controls the expression of genes encoding PTAs in the pancreatic lymph nodes (PLNs). The expression of canonical Deaf1 was lower, whereas that of an alternatively spliced variant was higher, during the onset of destructive insulitis in the PLNs of nonobese diabetic (NOD) mice. We identified an equivalent variant Deaf1 isoform in the PLNs of patients with type 1 diabetes. Both the NOD mouse and human Deaf1 variant isoforms suppressed PTA expression by inhibiting the transcriptional activity of canonical Deaf1. Lower PTA expression resulting from the alternative splicing of DEAF1 may contribute to the pathogenesis of type 1 diabetes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Expression of PTAs and Deaf1 isoforms in the PLNs of NOD mice.
Figure 2: Quantification of the expression of DF1 and DF1-VAR1 in NOD PLNs.
Figure 3: Cellular localization, formation of heterodimers and transcriptional activity of DF1 and DF1-VAR1.
Figure 4: Analysis of Deaf1-deficient mice.
Figure 5: Deaf1 regulates gene expression in NIH3T3 cells.
Figure 6: Regulation of PTA expression in NOD PLNs and LN CD45− cells by DF1 and DF1-VAR1.
Figure 7: Identification and characterization of an alternatively spliced Deaf1 isoform in human PLNs.

Accession codes

Accessions

GenBank/EMBL/DDBJ

Gene Expression Omnibus

References

  1. Anderson, M.S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395–1401 (2002).

    Article  CAS  Google Scholar 

  2. Lee, J.W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8, 181–190 (2007).

    Article  CAS  Google Scholar 

  3. Gardner, J.M. et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321, 843–847 (2008).

    Article  CAS  Google Scholar 

  4. Nichols, L.A. et al. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J. Immunol. 179, 993–1003 (2007).

    Article  CAS  Google Scholar 

  5. Kodama, K. et al. Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clin. Immunol. 129, 195–201 (2008).

    Article  CAS  Google Scholar 

  6. Lemonde, S. et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23, 8788–8799 (2003).

    Article  CAS  Google Scholar 

  7. Adorini, L., Gregori, S. & Harrison, L.C. Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. 8, 31–38 (2002).

    Article  CAS  Google Scholar 

  8. Huggenvik, J.I. et al. Characterization of a nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related (NUDR) transcriptional regulator protein. Mol. Endocrinol. 12, 1619–1639 (1998).

    Article  CAS  Google Scholar 

  9. Koh, A.S. et al. Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc. Natl. Acad. Sci. USA 105, 15878–15883 (2008).

    Article  CAS  Google Scholar 

  10. Org, T. et al. The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep. 9, 370–376 (2008).

    Article  CAS  Google Scholar 

  11. Jensik, P.J., Huggenvik, J.I. & Collard, M.W. Identification of a nuclear export signal and protein interaction domains in deformed epidermal autoregulatory factor-1 (DEAF-1). J. Biol. Chem. 279, 32692–32699 (2004).

    Article  CAS  Google Scholar 

  12. Bottomley, M.J. et al. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat. Struct. Biol. 8, 626–633 (2001).

    Article  CAS  Google Scholar 

  13. Czesak, M., Lemonde, S., Peterson, E.A., Rogaeva, A. & Albert, P.R. Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J. Neurosci. 26, 1864–1871 (2006).

    Article  CAS  Google Scholar 

  14. Lambe, T. et al. Limited peripheral T cell anergy predisposes to retinal autoimmunity. J. Immunol. 178, 4276–4283 (2007).

    Article  CAS  Google Scholar 

  15. Bennett, S.T. et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9, 284–292 (1995).

    Article  CAS  Google Scholar 

  16. Egwuagu, C.E., Charukamnoetkanok, P. & Gery, I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159, 3109–3112 (1997).

    CAS  PubMed  Google Scholar 

  17. Avichezer, D. et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J. Exp. Med. 198, 1665–1676 (2003).

    Article  CAS  Google Scholar 

  18. Venanzi, E.S., Melamed, R., Mathis, D. & Benoist, C. The variable immunological self: genetic variation and nongenetic noise in Aire-regulated transcription. Proc. Natl. Acad. Sci. USA 105, 15860–15865 (2008).

    Article  CAS  Google Scholar 

  19. Gavanescu, I., Kessler, B., Ploegh, H., Benoist, C. & Mathis, D. Loss of Aire-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity. Proc. Natl. Acad. Sci. USA 104, 4583–4587 (2007).

    Article  CAS  Google Scholar 

  20. Hahm, K. et al. Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol. Cell. Biol. 24, 2074–2082 (2004).

    Article  CAS  Google Scholar 

  21. Derbinski, J. et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202, 33–45 (2005).

    Article  CAS  Google Scholar 

  22. Derbinski, J., Schulte, A., Kyewski, B. & Klein, L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2, 1032–1039 (2001).

    Article  CAS  Google Scholar 

  23. Planas, R. et al. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNβ. Diabetologia 49, 2379–2387 (2006).

    Article  CAS  Google Scholar 

  24. Kasai, M., Kropshofer, H., Vogt, A.B., Kominami, E. & Mizuochi, T. CLIP-derived self peptides bound to MHC class II molecules of medullary thymic epithelial cells differ from those of cortical thymic epithelial cells in their diversity, length, and C-terminal processing. Eur. J. Immunol. 30, 3542–3551 (2000).

    Article  CAS  Google Scholar 

  25. Lynch, K.W. Consequences of regulated pre-mRNA splicing in the immune system. Nat. Rev. Immunol. 4, 931–940 (2004).

    Article  CAS  Google Scholar 

  26. Eissa, N.T. et al. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J. Biol. Chem. 271, 27184–27187 (1996).

    Article  CAS  Google Scholar 

  27. Gratchev, A. et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3. Scand. J. Immunol. 53, 386–392 (2001).

    Article  CAS  Google Scholar 

  28. Borsi, L., Castellani, P., Risso, A.M., Leprini, A. & Zardi, L. Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett. 261, 175–178 (1990).

    Article  CAS  Google Scholar 

  29. Togo, S., Shimokawa, T., Fukuchi, Y. & Ra, C. Alternative splicing of myeloid IgA Fc receptor (FcαR, CD89) transcripts in inflammatory responses. FEBS Lett. 535, 205–209 (2003).

    Article  CAS  Google Scholar 

  30. Cowling, R.T. et al. Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 289, H1176–H1183 (2005).

    Article  CAS  Google Scholar 

  31. Creusot, R.J. et al. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin. Immunol. 127, 176–187 (2008).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank H. Iwai and C. Taylor for technical assistance; J. Visvader (The Walter and Eliza Hall Institute of Medical Research) for Deaf1-deficient mice; and the Network for Pancreatic Organ Donors with Diabetes (Juvenile Diabetes Research Foundation) and the National Disease Research Interchange for human PLNs and spleen samples. Supported by the US National Institutes of Health (U01 DK078123-03, U19-DK 61934 and U19-AI050864 to C.G.F.), the Canadian Institutes of Health Research (P.R.A. and M.C.) and the American Diabetes Association (L.Y.).

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA

    Linda Yip, Leon Su, Deqiao Sheng, Pearl Chang, C Garrison Fathman & Rémi J Creusot

  2. Department of Pathology, University of Florida, Gainesville, Florida, USA

    Mark Atkinson

  3. Ottawa Health Research Institute (Neuroscience) and Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada

    Margaret Czesak & Paul R Albert

  4. Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, Massachusetts, USA

    Ai-Ris Collier & Shannon J Turley

Authors
  1. Linda Yip
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leon Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deqiao Sheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pearl Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mark Atkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Margaret Czesak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paul R Albert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ai-Ris Collier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shannon J Turley
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C Garrison Fathman
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rémi J Creusot
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

L.Y. did microarray and quantitative PCR assays, cloned full-length DF1-VAR1 and Hu-DF1-VAR, synthesized DF1-VAR1, Hu-DF1 and Hu-DF1-VAR, did subcellular localization and siRNA experiments, assessed Deaf1-deficient mice for lymphocyte infiltration and serum autoantibodies, prepared the manuscript and composed the figures; R.J.C. extracted tissues for microarray and quantitative PCR, isolated cellular subsets from PLNs and, with P.C., isolated and immortalized the CD45− cells; D.S. cloned the DF1 isoform and synthesized DF1 fusion proteins; M.A. (and the Network for Pancreatic Organ Donors with Diabetes) provided human PLNs and spleen samples; M.C. and P.R.A. provided the Deaf1-deficient mice and provided guidance on work with these mice; A.-R.C. and S.J.T. provided expertise and guidance on the isolation of the CD45− lymph node stromal elements; L.S. did the immunoblot, coimmunoprecipitation and luciferase reporter assays and, with C.G.F., R.J.C. and L.Y., was involved in all aspects of the planning and direction of this work; all authors reviewed and edited the manuscript; and C.G.F. provided most of the funding.

Corresponding author

Correspondence to C Garrison Fathman.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–7 and Supplementary Tables 1–4 (PDF 2441 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yip, L., Su, L., Sheng, D. et al. Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes. Nat Immunol 10, 1026–1033 (2009). https://doi.org/10.1038/ni.1773

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.1773

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing